mosapride is an approved drug
Compound class:
Synthetic organic
Comment: Marketed formulations contain mosapride citrate (PubChem CID 119583).
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
No information available. |
Summary of Clinical Use |
Mosapride is not approved by the US FDA or EMA. Other national approval agencies (mainly in South America and East Asia) have authorised its clinical use. Where approved, mosapride is used to treat gastrointestinal disorders [2], as it acts to accelerate gastric emptying. |
Mechanism Of Action and Pharmacodynamic Effects |
Mosapride a selective agonist of the serotonin 5-HT4 receptor [3]. |